These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 21617592)

  • 1. Dexmedetomidine (Precedex) for ICU sedation.
    Med Lett Drugs Ther; 2011 May; 53(1365):41-2. PubMed ID: 21617592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexmedetomidine in the treatment of withdrawal syndromes in cardiothoracic surgery patients.
    Baddigam K; Russo P; Russo J; Tobias JD
    J Intensive Care Med; 2005; 20(2):118-23. PubMed ID: 15855224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit.
    Martin E; Ramsay G; Mantz J; Sum-Ping ST
    J Intensive Care Med; 2003; 18(1):29-41. PubMed ID: 15189665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine: a review of clinical applications.
    Carollo DS; Nossaman BD; Ramadhyani U
    Curr Opin Anaesthesiol; 2008 Aug; 21(4):457-61. PubMed ID: 18660652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating agitation with dexmedetomidine in the ICU.
    Boyer J
    Dimens Crit Care Nurs; 2009; 28(3):102-9. PubMed ID: 19387269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of dexmedetomidine and propofol for short-term sedation in early postoperative period after cardiac surgery].
    Eremenko AA; Chemova EV
    Anesteziol Reanimatol; 2014; (2):37-41. PubMed ID: 25055491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive dexmedetomidine therapy in the intensive care unit: a retrospective assessment of impact on sedative and analgesic requirements, levels of sedation and analgesia, and ventilatory and hemodynamic parameters.
    MacLaren R; Forrest LK; Kiser TH
    Pharmacotherapy; 2007 Mar; 27(3):351-9. PubMed ID: 17316147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dexmedetomidine on delirium duration of non-intubated ICU patients (4D trial): study protocol for a randomized trial.
    Louis C; Godet T; Chanques G; Bourguignon N; Morand D; Pereira B; Constantin JM;
    Trials; 2018 Jun; 19(1):307. PubMed ID: 29866205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of dexmedetomidine for the prevention and treatment of delirium in intensive care unit patients.
    Mo Y; Zimmermann AE
    Ann Pharmacother; 2013 Jun; 47(6):869-76. PubMed ID: 23719785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose dexmedetomidine for sedation in the intensive care unit: an evaluation of clinical efficacy and safety.
    Jones GM; Murphy CV; Gerlach AT; Goodman EM; Pell LJ
    Ann Pharmacother; 2011 Jun; 45(6):740-7. PubMed ID: 21666095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An updated focused review of dexmedetomidine in adults.
    Gerlach AT; Murphy CV; Dasta JF
    Ann Pharmacother; 2009 Dec; 43(12):2064-74. PubMed ID: 19934395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit.
    Dasta JF; Kane-Gill SL; Pencina M; Shehabi Y; Bokesch PM; Wisemandle W; Riker RR
    Crit Care Med; 2010 Feb; 38(2):497-503. PubMed ID: 19789442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altering intensive care sedation paradigms to improve patient outcomes.
    Riker RR; Fraser GL
    Crit Care Clin; 2009 Jul; 25(3):527-38, viii-ix. PubMed ID: 19576528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit.
    Venn M; Newman J; Grounds M
    Intensive Care Med; 2003 Feb; 29(2):201-7. PubMed ID: 12594584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of dexmedetomidine in patients with noninvasive ventilation: a preliminary study.
    Akada S; Takeda S; Yoshida Y; Nakazato K; Mori M; Hongo T; Tanaka K; Sakamoto A
    Anesth Analg; 2008 Jul; 107(1):167-70. PubMed ID: 18635484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical benefits of dexmedetomidine versus propofol in adult intensive care unit patients: a meta-analysis of randomized clinical trials.
    Xia ZQ; Chen SQ; Yao X; Xie CB; Wen SH; Liu KX
    J Surg Res; 2013 Dec; 185(2):833-43. PubMed ID: 23910886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of dexmedetomidine in facilitating extubation in the intensive care unit.
    Arpino PA; Kalafatas K; Thompson BT
    J Clin Pharm Ther; 2008 Feb; 33(1):25-30. PubMed ID: 18211613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexmedetomidine sedation: uses in pediatric procedural sedation outside the operating room.
    McMorrow SP; Abramo TJ
    Pediatr Emerg Care; 2012 Mar; 28(3):292-6. PubMed ID: 22391930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of dexmedetomidine on analgesic requirements in patients after cardiac surgery in a fast-track recovery room setting.
    Barletta JF; Miedema SL; Wiseman D; Heiser JC; McAllen KJ
    Pharmacotherapy; 2009 Dec; 29(12):1427-32. PubMed ID: 19947802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine: a review of its use for the management of pain, agitation, and delirium in the intensive care unit.
    Anger KE
    Curr Pharm Des; 2013; 19(22):4003-13. PubMed ID: 23228319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.